Literature DB >> 667835

Folate and pterin metabolism by cancer cells in culture.

B Stea, P S Backlund, P B Berkey, A K Cho, B C Halpern, R M Halpern, R A Smith.   

Abstract

Malignant cells grown in culture excrete into their growth medium a folate catabolite that can be seen as a blue-fluorescent region on paper chromatograms of such media. This folate catabolite has now been identified by paper chromatography, thin-layer chromatography, and combined gas chromatography-mass spectrometry as 6- hydroxymethylpterin and not as pterin-6-carboxaldehyde as previously reported. Moreover, when pterin-6-carboxaldehyde was added to the growth medium of logarithmically growing malignant cells, it was primarily reduced to 6-hydroxymethylpterin. In contrast pterin-6-carboxylate was the principal product formed from added pterin-6-carboxaldehyde by normal established cell lines in culture. These results have been interpreted as indicative of a possible mechanism of folate catabolism in malignant cells. Folic acid or another folate derivative is oxidatively cleaved at the C-9-N-10 bond to yield pterin-6-carboxaldehyde as one of the products. This derivative is subsequently reduced to 6-hydroxymethylpterin, which is excreted into the growth medium.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667835

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Unconjugated pteridines and the activation of macrophages by interferon gamma.

Authors:  G Reibnegger; D Fuchs; A Hausen; E R Werner; G Werner-Felmayer; H Wachter
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Urinary unconjugated pteridines: general considerations.

Authors:  B Stea; R A Smith
Journal:  Surv Immunol Res       Date:  1982

3.  Establishing pteridine metabolism in a progressive isogenic breast cancer cell model.

Authors:  Lindsey Rasmussen; Zachary Foulks; Casey Burton; Honglan Shi
Journal:  Metabolomics       Date:  2021-12-17       Impact factor: 4.290

4.  The transport of pteridines in CCRF-CEM human lymphoblastic cells.

Authors:  S Webber; R Nazarbaghi
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  A survey of the location, isolation and identification of indoles, pteridines and some unknown active substances in sheep pineals. The possible significance of pteridines for the neuroendocrine control of neoplastic growth.

Authors:  I Ebels
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

6.  Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate.

Authors:  G P Browman; L Booker; P Spiegl
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Measurement of urinary neopterin in normal pregnant and non-pregnant women and in women with benign and malignant genital tract neoplasms.

Authors:  A Bichler; D Fuchs; A Hausen; H Hetzel; G Reibnegger; H Wachter
Journal:  Arch Gynecol       Date:  1983

8.  Characterization of the folic acid C9-N10-cleaving enzyme of Dictyostelium minutum V3.

Authors:  R J De Wit; R J van der Velden; T M Konijn
Journal:  J Bacteriol       Date:  1983-05       Impact factor: 3.490

9.  Folate catabolism in tumour-bearing rats and rats treated with methotrexate.

Authors:  A M Saleh; A E Pheasant; J A Blair
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.